aluates Reports

$ 0.0

Automative

Global Novel Vaccine Delivery Systems Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-33I9876

Global Novel Vaccine Delivery Systems Market Research Report 2022

BUY CHAPTERS

Global Novel Vaccine Delivery Systems Market Research Report 2025

Code: QYRE-Auto-33I9876

Report

March 2025

Pages:86

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Becton

Dickinson

Carl Zeiss Foundation

Gerresheimer

Corium International

Inovio Pharmaceuticals

Bioject Medical Technologies

PharmaJet

Retractable Technologies

Terumo Corporation

Vaxxas

Altaris Capital Partners

Kindeva Drug Delivery

Novel Vaccine Delivery Systems Market Size

The global market for Novel Vaccine Delivery Systems was valued at US$ 7163 million in the year 2024 and is projected to reach a revised size of US$ 14540 million by 2031, growing at a CAGR of 10.8% during the forecast period.

Novel Vaccine Delivery Systems Market

Novel vaccine delivery includes formulations, technologies, methods, and systems to transfer an active pharmaceutical ingredient in the body, as desired, in order to safely accomplish its therapeutic effect.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Novel Vaccine Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Novel Vaccine Delivery Systems.

The Novel Vaccine Delivery Systems market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Novel Vaccine Delivery Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Novel Vaccine Delivery Systems companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Novel Vaccine Delivery Systems Market Report

Report Metric	Details
Report Name	Novel Vaccine Delivery Systems Market
Accounted market size in year	US$ 7163 million
Forecasted market size in 2031	US$ 14540 million
CAGR	10.8%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Intradermal Delivery Intramuscular Delivery Others
Segment by Application	Hospitals & Clinics Research Institutes Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Altaris Capital Partners, Kindeva Drug Delivery, Becton, Dickinson,, Carl Zeiss Foundation, Gerresheimer AG, Corium International, Inovio Pharmaceuticals, Bioject Medical Technologies, PharmaJet, Retractable Technologies, Terumo Corporation, VAXXAS
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Novel Vaccine Delivery Systems company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Novel Vaccine Delivery Systems Market growing?

Ans: The Novel Vaccine Delivery Systems Market witnessing a CAGR of 10.8% during the forecast period 2025-2031.

What is the Novel Vaccine Delivery Systems Market size in 2031?

Ans: The Novel Vaccine Delivery Systems Market size in 2031 will be US$ 14540 million.

Who are the main players in the Novel Vaccine Delivery Systems Market report?

Ans: The main players in the Novel Vaccine Delivery Systems Market are Altaris Capital Partners, Kindeva Drug Delivery, Becton, Dickinson,, Carl Zeiss Foundation, Gerresheimer AG, Corium International, Inovio Pharmaceuticals, Bioject Medical Technologies, PharmaJet, Retractable Technologies, Terumo Corporation, VAXXAS

What are the Application segmentation covered in the Novel Vaccine Delivery Systems Market report?

Ans: The Applications covered in the Novel Vaccine Delivery Systems Market report are Hospitals & Clinics, Research Institutes, Others

What are the Type segmentation covered in the Novel Vaccine Delivery Systems Market report?

Ans: The Types covered in the Novel Vaccine Delivery Systems Market report are Intradermal Delivery, Intramuscular Delivery, Others

Recommended Reports

Vaccine Markets

Drug Delivery Systems

Modern Vaccines

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Novel Vaccine Delivery Systems Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Intradermal Delivery

1.2.3 Intramuscular Delivery

1.2.4 Others

1.3 Market by Application

1.3.1 Global Novel Vaccine Delivery Systems Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals & Clinics

1.3.3 Research Institutes

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Novel Vaccine Delivery Systems Market Perspective (2020-2031)

2.2 Global Novel Vaccine Delivery Systems Growth Trends by Region

2.2.1 Global Novel Vaccine Delivery Systems Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Novel Vaccine Delivery Systems Historic Market Size by Region (2020-2025)

2.2.3 Novel Vaccine Delivery Systems Forecasted Market Size by Region (2026-2031)

2.3 Novel Vaccine Delivery Systems Market Dynamics

2.3.1 Novel Vaccine Delivery Systems Industry Trends

2.3.2 Novel Vaccine Delivery Systems Market Drivers

2.3.3 Novel Vaccine Delivery Systems Market Challenges

2.3.4 Novel Vaccine Delivery Systems Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Novel Vaccine Delivery Systems Players by Revenue

3.1.1 Global Top Novel Vaccine Delivery Systems Players by Revenue (2020-2025)

3.1.2 Global Novel Vaccine Delivery Systems Revenue Market Share by Players (2020-2025)

3.2 Global Novel Vaccine Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Novel Vaccine Delivery Systems Revenue

3.4 Global Novel Vaccine Delivery Systems Market Concentration Ratio

3.4.1 Global Novel Vaccine Delivery Systems Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Novel Vaccine Delivery Systems Revenue in 2024

3.5 Global Key Players of Novel Vaccine Delivery Systems Head office and Area Served

3.6 Global Key Players of Novel Vaccine Delivery Systems, Product and Application

3.7 Global Key Players of Novel Vaccine Delivery Systems, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Novel Vaccine Delivery Systems Breakdown Data by Type

4.1 Global Novel Vaccine Delivery Systems Historic Market Size by Type (2020-2025)

4.2 Global Novel Vaccine Delivery Systems Forecasted Market Size by Type (2026-2031)

5 Novel Vaccine Delivery Systems Breakdown Data by Application

5.1 Global Novel Vaccine Delivery Systems Historic Market Size by Application (2020-2025)

5.2 Global Novel Vaccine Delivery Systems Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Novel Vaccine Delivery Systems Market Size (2020-2031)

6.2 North America Novel Vaccine Delivery Systems Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Novel Vaccine Delivery Systems Market Size by Country (2020-2025)

6.4 North America Novel Vaccine Delivery Systems Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Novel Vaccine Delivery Systems Market Size (2020-2031)

7.2 Europe Novel Vaccine Delivery Systems Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Novel Vaccine Delivery Systems Market Size by Country (2020-2025)

7.4 Europe Novel Vaccine Delivery Systems Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Novel Vaccine Delivery Systems Market Size (2020-2031)

8.2 Asia-Pacific Novel Vaccine Delivery Systems Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Novel Vaccine Delivery Systems Market Size by Region (2020-2025)

8.4 Asia-Pacific Novel Vaccine Delivery Systems Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Novel Vaccine Delivery Systems Market Size (2020-2031)

9.2 Latin America Novel Vaccine Delivery Systems Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Novel Vaccine Delivery Systems Market Size by Country (2020-2025)

9.4 Latin America Novel Vaccine Delivery Systems Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Novel Vaccine Delivery Systems Market Size (2020-2031)

10.2 Middle East & Africa Novel Vaccine Delivery Systems Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Novel Vaccine Delivery Systems Market Size by Country (2020-2025)

10.4 Middle East & Africa Novel Vaccine Delivery Systems Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Altaris Capital Partners

11.1.1 Altaris Capital Partners Company Details

11.1.2 Altaris Capital Partners Business Overview

11.1.3 Altaris Capital Partners Novel Vaccine Delivery Systems Introduction

11.1.4 Altaris Capital Partners Revenue in Novel Vaccine Delivery Systems Business (2020-2025)

11.1.5 Altaris Capital Partners Recent Development

11.2 Kindeva Drug Delivery

11.2.1 Kindeva Drug Delivery Company Details

11.2.2 Kindeva Drug Delivery Business Overview

11.2.3 Kindeva Drug Delivery Novel Vaccine Delivery Systems Introduction

11.2.4 Kindeva Drug Delivery Revenue in Novel Vaccine Delivery Systems Business (2020-2025)

11.2.5 Kindeva Drug Delivery Recent Development

11.3 Becton

11.3.1 Becton Company Details

11.3.2 Becton Business Overview

11.3.3 Becton Novel Vaccine Delivery Systems Introduction

11.3.4 Becton Revenue in Novel Vaccine Delivery Systems Business (2020-2025)

11.3.5 Becton Recent Development

11.4 Dickinson,

11.4.1 Dickinson, Company Details

11.4.2 Dickinson, Business Overview

11.4.3 Dickinson, Novel Vaccine Delivery Systems Introduction

11.4.4 Dickinson, Revenue in Novel Vaccine Delivery Systems Business (2020-2025)

11.4.5 Dickinson, Recent Development

11.5 Carl Zeiss Foundation

11.5.1 Carl Zeiss Foundation Company Details

11.5.2 Carl Zeiss Foundation Business Overview

11.5.3 Carl Zeiss Foundation Novel Vaccine Delivery Systems Introduction

11.5.4 Carl Zeiss Foundation Revenue in Novel Vaccine Delivery Systems Business (2020-2025)

11.5.5 Carl Zeiss Foundation Recent Development

11.6 Gerresheimer AG

11.6.1 Gerresheimer AG Company Details

11.6.2 Gerresheimer AG Business Overview

11.6.3 Gerresheimer AG Novel Vaccine Delivery Systems Introduction

11.6.4 Gerresheimer AG Revenue in Novel Vaccine Delivery Systems Business (2020-2025)

11.6.5 Gerresheimer AG Recent Development

11.7 Corium International

11.7.1 Corium International Company Details

11.7.2 Corium International Business Overview

11.7.3 Corium International Novel Vaccine Delivery Systems Introduction

11.7.4 Corium International Revenue in Novel Vaccine Delivery Systems Business (2020-2025)

11.7.5 Corium International Recent Development

11.8 Inovio Pharmaceuticals

11.8.1 Inovio Pharmaceuticals Company Details

11.8.2 Inovio Pharmaceuticals Business Overview

11.8.3 Inovio Pharmaceuticals Novel Vaccine Delivery Systems Introduction

11.8.4 Inovio Pharmaceuticals Revenue in Novel Vaccine Delivery Systems Business (2020-2025)

11.8.5 Inovio Pharmaceuticals Recent Development

11.9 Bioject Medical Technologies

11.9.1 Bioject Medical Technologies Company Details

11.9.2 Bioject Medical Technologies Business Overview

11.9.3 Bioject Medical Technologies Novel Vaccine Delivery Systems Introduction

11.9.4 Bioject Medical Technologies Revenue in Novel Vaccine Delivery Systems Business (2020-2025)

11.9.5 Bioject Medical Technologies Recent Development

11.10 PharmaJet

11.10.1 PharmaJet Company Details

11.10.2 PharmaJet Business Overview

11.10.3 PharmaJet Novel Vaccine Delivery Systems Introduction

11.10.4 PharmaJet Revenue in Novel Vaccine Delivery Systems Business (2020-2025)

11.10.5 PharmaJet Recent Development

11.11 Retractable Technologies

11.11.1 Retractable Technologies Company Details

11.11.2 Retractable Technologies Business Overview

11.11.3 Retractable Technologies Novel Vaccine Delivery Systems Introduction

11.11.4 Retractable Technologies Revenue in Novel Vaccine Delivery Systems Business (2020-2025)

11.11.5 Retractable Technologies Recent Development

11.12 Terumo Corporation

11.12.1 Terumo Corporation Company Details

11.12.2 Terumo Corporation Business Overview

11.12.3 Terumo Corporation Novel Vaccine Delivery Systems Introduction

11.12.4 Terumo Corporation Revenue in Novel Vaccine Delivery Systems Business (2020-2025)

11.12.5 Terumo Corporation Recent Development

11.13 VAXXAS

11.13.1 VAXXAS Company Details

11.13.2 VAXXAS Business Overview

11.13.3 VAXXAS Novel Vaccine Delivery Systems Introduction

11.13.4 VAXXAS Revenue in Novel Vaccine Delivery Systems Business (2020-2025)

11.13.5 VAXXAS Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Becton

Dickinson

Carl Zeiss Foundation

Gerresheimer

Corium International

Inovio Pharmaceuticals

Bioject Medical Technologies

PharmaJet

Retractable Technologies

Terumo Corporation

Vaxxas

Altaris Capital Partners

Kindeva Drug Delivery

List of Tables

Table 1. Global Novel Vaccine Delivery Systems Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Intradermal Delivery

Table 3. Key Players of Intramuscular Delivery

Table 4. Key Players of Others

Table 5. Global Novel Vaccine Delivery Systems Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Novel Vaccine Delivery Systems Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Novel Vaccine Delivery Systems Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Novel Vaccine Delivery Systems Market Share by Region (2020-2025)

Table 9. Global Novel Vaccine Delivery Systems Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Novel Vaccine Delivery Systems Market Share by Region (2026-2031)

Table 11. Novel Vaccine Delivery Systems Market Trends

Table 12. Novel Vaccine Delivery Systems Market Drivers

Table 13. Novel Vaccine Delivery Systems Market Challenges

Table 14. Novel Vaccine Delivery Systems Market Restraints

Table 15. Global Novel Vaccine Delivery Systems Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Novel Vaccine Delivery Systems Market Share by Players (2020-2025)

Table 17. Global Top Novel Vaccine Delivery Systems Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Novel Vaccine Delivery Systems as of 2024)

Table 18. Ranking of Global Top Novel Vaccine Delivery Systems Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Novel Vaccine Delivery Systems Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Novel Vaccine Delivery Systems, Headquarters and Area Served

Table 21. Global Key Players of Novel Vaccine Delivery Systems, Product and Application

Table 22. Global Key Players of Novel Vaccine Delivery Systems, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Novel Vaccine Delivery Systems Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Novel Vaccine Delivery Systems Revenue Market Share by Type (2020-2025)

Table 26. Global Novel Vaccine Delivery Systems Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Novel Vaccine Delivery Systems Revenue Market Share by Type (2026-2031)

Table 28. Global Novel Vaccine Delivery Systems Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Novel Vaccine Delivery Systems Revenue Market Share by Application (2020-2025)

Table 30. Global Novel Vaccine Delivery Systems Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Novel Vaccine Delivery Systems Revenue Market Share by Application (2026-2031)

Table 32. North America Novel Vaccine Delivery Systems Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Novel Vaccine Delivery Systems Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Novel Vaccine Delivery Systems Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Novel Vaccine Delivery Systems Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Novel Vaccine Delivery Systems Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Novel Vaccine Delivery Systems Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Novel Vaccine Delivery Systems Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Novel Vaccine Delivery Systems Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Novel Vaccine Delivery Systems Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Novel Vaccine Delivery Systems Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Novel Vaccine Delivery Systems Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Novel Vaccine Delivery Systems Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Novel Vaccine Delivery Systems Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Novel Vaccine Delivery Systems Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Novel Vaccine Delivery Systems Market Size by Country (2026-2031) & (US$ Million)

Table 47. Altaris Capital Partners Company Details

Table 48. Altaris Capital Partners Business Overview

Table 49. Altaris Capital Partners Novel Vaccine Delivery Systems Product

Table 50. Altaris Capital Partners Revenue in Novel Vaccine Delivery Systems Business (2020-2025) & (US$ Million)

Table 51. Altaris Capital Partners Recent Development

Table 52. Kindeva Drug Delivery Company Details

Table 53. Kindeva Drug Delivery Business Overview

Table 54. Kindeva Drug Delivery Novel Vaccine Delivery Systems Product

Table 55. Kindeva Drug Delivery Revenue in Novel Vaccine Delivery Systems Business (2020-2025) & (US$ Million)

Table 56. Kindeva Drug Delivery Recent Development

Table 57. Becton Company Details

Table 58. Becton Business Overview

Table 59. Becton Novel Vaccine Delivery Systems Product

Table 60. Becton Revenue in Novel Vaccine Delivery Systems Business (2020-2025) & (US$ Million)

Table 61. Becton Recent Development

Table 62. Dickinson, Company Details

Table 63. Dickinson, Business Overview

Table 64. Dickinson, Novel Vaccine Delivery Systems Product

Table 65. Dickinson, Revenue in Novel Vaccine Delivery Systems Business (2020-2025) & (US$ Million)

Table 66. Dickinson, Recent Development

Table 67. Carl Zeiss Foundation Company Details

Table 68. Carl Zeiss Foundation Business Overview

Table 69. Carl Zeiss Foundation Novel Vaccine Delivery Systems Product

Table 70. Carl Zeiss Foundation Revenue in Novel Vaccine Delivery Systems Business (2020-2025) & (US$ Million)

Table 71. Carl Zeiss Foundation Recent Development

Table 72. Gerresheimer AG Company Details

Table 73. Gerresheimer AG Business Overview

Table 74. Gerresheimer AG Novel Vaccine Delivery Systems Product

Table 75. Gerresheimer AG Revenue in Novel Vaccine Delivery Systems Business (2020-2025) & (US$ Million)

Table 76. Gerresheimer AG Recent Development

Table 77. Corium International Company Details

Table 78. Corium International Business Overview

Table 79. Corium International Novel Vaccine Delivery Systems Product

Table 80. Corium International Revenue in Novel Vaccine Delivery Systems Business (2020-2025) & (US$ Million)

Table 81. Corium International Recent Development

Table 82. Inovio Pharmaceuticals Company Details

Table 83. Inovio Pharmaceuticals Business Overview

Table 84. Inovio Pharmaceuticals Novel Vaccine Delivery Systems Product

Table 85. Inovio Pharmaceuticals Revenue in Novel Vaccine Delivery Systems Business (2020-2025) & (US$ Million)

Table 86. Inovio Pharmaceuticals Recent Development

Table 87. Bioject Medical Technologies Company Details

Table 88. Bioject Medical Technologies Business Overview

Table 89. Bioject Medical Technologies Novel Vaccine Delivery Systems Product

Table 90. Bioject Medical Technologies Revenue in Novel Vaccine Delivery Systems Business (2020-2025) & (US$ Million)

Table 91. Bioject Medical Technologies Recent Development

Table 92. PharmaJet Company Details

Table 93. PharmaJet Business Overview

Table 94. PharmaJet Novel Vaccine Delivery Systems Product

Table 95. PharmaJet Revenue in Novel Vaccine Delivery Systems Business (2020-2025) & (US$ Million)

Table 96. PharmaJet Recent Development

Table 97. Retractable Technologies Company Details

Table 98. Retractable Technologies Business Overview

Table 99. Retractable Technologies Novel Vaccine Delivery Systems Product

Table 100. Retractable Technologies Revenue in Novel Vaccine Delivery Systems Business (2020-2025) & (US$ Million)

Table 101. Retractable Technologies Recent Development

Table 102. Terumo Corporation Company Details

Table 103. Terumo Corporation Business Overview

Table 104. Terumo Corporation Novel Vaccine Delivery Systems Product

Table 105. Terumo Corporation Revenue in Novel Vaccine Delivery Systems Business (2020-2025) & (US$ Million)

Table 106. Terumo Corporation Recent Development

Table 107. VAXXAS Company Details

Table 108. VAXXAS Business Overview

Table 109. VAXXAS Novel Vaccine Delivery Systems Product

Table 110. VAXXAS Revenue in Novel Vaccine Delivery Systems Business (2020-2025) & (US$ Million)

Table 111. VAXXAS Recent Development

Table 112. Research Programs/Design for This Report

Table 113. Key Data Information from Secondary Sources

Table 114. Key Data Information from Primary Sources

Table 115. Authors List of This Report

List of Figures

Figure 1. Novel Vaccine Delivery Systems Picture

Figure 2. Global Novel Vaccine Delivery Systems Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Novel Vaccine Delivery Systems Market Share by Type: 2024 VS 2031

Figure 4. Intradermal Delivery Features

Figure 5. Intramuscular Delivery Features

Figure 6. Others Features

Figure 7. Global Novel Vaccine Delivery Systems Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Novel Vaccine Delivery Systems Market Share by Application: 2024 VS 2031

Figure 9. Hospitals & Clinics Case Studies

Figure 10. Research Institutes Case Studies

Figure 11. Others Case Studies

Figure 12. Novel Vaccine Delivery Systems Report Years Considered

Figure 13. Global Novel Vaccine Delivery Systems Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Novel Vaccine Delivery Systems Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Novel Vaccine Delivery Systems Market Share by Region: 2024 VS 2031

Figure 16. Global Novel Vaccine Delivery Systems Market Share by Players in 2024

Figure 17. Global Top Novel Vaccine Delivery Systems Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Novel Vaccine Delivery Systems as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Novel Vaccine Delivery Systems Revenue in 2024

Figure 19. North America Novel Vaccine Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Novel Vaccine Delivery Systems Market Share by Country (2020-2031)

Figure 21. United States Novel Vaccine Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Novel Vaccine Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Novel Vaccine Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Novel Vaccine Delivery Systems Market Share by Country (2020-2031)

Figure 25. Germany Novel Vaccine Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Novel Vaccine Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Novel Vaccine Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Novel Vaccine Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Novel Vaccine Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Novel Vaccine Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Novel Vaccine Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Novel Vaccine Delivery Systems Market Share by Region (2020-2031)

Figure 33. China Novel Vaccine Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Novel Vaccine Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Novel Vaccine Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Novel Vaccine Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Novel Vaccine Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Novel Vaccine Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Novel Vaccine Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Novel Vaccine Delivery Systems Market Share by Country (2020-2031)

Figure 41. Mexico Novel Vaccine Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Novel Vaccine Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Novel Vaccine Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Novel Vaccine Delivery Systems Market Share by Country (2020-2031)

Figure 45. Turkey Novel Vaccine Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Novel Vaccine Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Novel Vaccine Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Altaris Capital Partners Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2020-2025)

Figure 49. Kindeva Drug Delivery Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2020-2025)

Figure 50. Becton Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2020-2025)

Figure 51. Dickinson, Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2020-2025)

Figure 52. Carl Zeiss Foundation Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2020-2025)

Figure 53. Gerresheimer AG Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2020-2025)

Figure 54. Corium International Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2020-2025)

Figure 55. Inovio Pharmaceuticals Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2020-2025)

Figure 56. Bioject Medical Technologies Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2020-2025)

Figure 57. PharmaJet Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2020-2025)

Figure 58. Retractable Technologies Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2020-2025)

Figure 59. Terumo Corporation Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2020-2025)

Figure 60. VAXXAS Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2020-2025)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Pharmaceutical Drug Delivery Technologies Market Insights Forecast to 2030

Oral Vaccine Delivery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pharmaceutical Drug Delivery Devices Market Insights Forecast to 2030

Global Oral Delivery Vaccines Market Research Report 2025

Global Noninvasive Delivery Vaccine Market Research Report 2025

Dental Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Orally Administered Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Targeted Drug Delivery System Market Research Report 2025

Next Generation Diabetes Therapy and Drug Delivery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oral Vaccination Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Intranasal Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oral Vaccine for Human Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Intranasal Drug and Vaccine Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Technologies for Delivery of Proteins Antibodies and Nucleic Acids Market Insights Forecast to 2030

Global Drug Delivery Technology Market Research Report 2024

Injectable Drug Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Combination Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Delivery Systems in Personal Care Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030

Global Novel Drug Delivery Systems Market Research Report 2025

RELATED REPORTS

Global Geriatric Care Services Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-17Q6174

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Hospice Software Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-8Z4276

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Geriatric Care Devices Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-8Q8325

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Allied Health Care Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29V19536

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions